We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $60.8B
1-Year Est. Return 42.06%
This Fund
S&P 500
This Quarter Est. Return
+9.93%
1 Year Est. Return
+42.06%
3 Year Est. Return
+131.09%
5 Year Est. Return
+176.11%
10 Year Est. Return
AUM
$49.3B
AUM Growth
+$3.1B
Cap. Flow
-$516M
Cap. Flow %
-1.05%
Top 10 Hldgs %
27.74%
Holding
1,796
New
24
Increased
581
Reduced
361
Closed
35

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$78.5M
2
NVDA icon
NVIDIA
NVDA
+$75.6M
3
LLY icon
Eli Lilly
LLY
+$70.2M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$58.7M
5
META icon
Meta Platforms (Facebook)
META
+$55.5M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$107M
2
PFE icon
Pfizer
PFE
+$70M
3
JNJ icon
Johnson & Johnson
JNJ
+$68M
4
DHR icon
Danaher
DHR
+$56.4M
5
WMT icon
Walmart Inc
WMT
+$54.2M

Sector Composition

Rank Sector Weight
1 Technology 25.47%
2 Healthcare 17.5%
3 Financials 11.6%
4 Consumer Discretionary 9.63%
5 Industrials 7.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCEL
1751
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$103K ﹤0.01%
105,283
OLPX
1752
DELISTED
Olaplex Holdings
OLPX
$93.6K ﹤0.01%
25,167
VIRX
1753
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$89.4K ﹤0.01%
63,406
SERA icon
1754
Sera Prognostics
SERA
$79.7M
$59.7K ﹤0.01%
18,108
LBTYA icon
1755
Liberty Global Class A
LBTYA
$3.62B
$54.8K ﹤0.01%
3,250
AMWL icon
1756
American Well
AMWL
$221M
$28.6K ﹤0.01%
681
KRON
1757
DELISTED
Kronos Bio
KRON
$27.8K ﹤0.01%
16,150
SYBX
1758
DELISTED
Synlogic
SYBX
$14.2K ﹤0.01%
2,207
XLB icon
1759
State Street Materials Select Sector SPDR ETF
XLB
$8.64B
$6.13K ﹤0.01%
148
DNA.WS
1760
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
$4.22K ﹤0.01%
16,100
AMED
1761
DELISTED
Amedisys
AMED
-215,099
Closed -$15.8M
AMR icon
1762
Alpha Metallurgical Resources
AMR
$2.86B
-4,790
Closed -$747K
BARK icon
1763
BARK
BARK
$97M
-29,536
Closed -$857K
CDLX icon
1764
Cardlytics
CDLX
$21.3M
-4,782
Closed -$162K
GBIO
1765
DELISTED
Generation Bio
GBIO
-3,064
Closed -$132K
IHRT icon
1766
iHeartMedia
IHRT
$435M
-74,130
Closed -$289K
LUMN icon
1767
Lumen
LUMN
$6.98B
-414,335
Closed -$1.1M
MLTX icon
1768
MoonLake Immunotherapeutics
MLTX
$1.28B
-11,575
Closed -$248K
NKTX icon
1769
Nkarta
NKTX
$209M
-28,265
Closed -$100K
TEAD
1770
Teads Holding Co
TEAD
$49.4M
-999,912
Closed -$4.13M
OVV icon
1771
Ovintiv
OVV
$17.9B
-34,120
Closed -$1.23M
SPY icon
1772
State Street SPDR S&P 500 ETF Trust
SPY
$814B
-110,000
Closed -$45M
TCOM icon
1773
Trip.com Group
TCOM
$25.8B
-56,550
Closed -$2.13M
TECK icon
1774
Teck Resources
TECK
$33.9B
-31,388
Closed -$1.15M
XLU icon
1775
State Street Utilities Select Sector SPDR ETF
XLU
$22.4B
-400,000
Closed -$13.5M

Similar funds

Ensign Peak Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Ensign Peak Advisors held 1,796 positions worth $49.3B, up 6.7% from $46.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Trading was light in Q2 2023: portfolio turnover was 3.3%. Ensign Peak Advisors opened 24 new positions and exited 35, leaving the 1,796-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

  • Ensign Peak Advisors's largest Q2 2023 buy was First Horizon: 875,834 shares worth $9.87M.
  • Ensign Peak Advisors added most to Microsoft in Q2 2023, an estimated $78.5M increase.
  • Ensign Peak Advisors's biggest Q2 2023 reduction was AbbVie, cutting an estimated $107M.
  • Ensign Peak Advisors fully exited State Street SPDR S&P 500 ETF Trust in Q2 2023, selling an estimated $45M.
  • Ensign Peak Advisors's ten largest holdings make up 28% of its $49.3B portfolio in Q2 2023.
  • Ensign Peak Advisors opened 24 new positions and closed 35 in Q2 2023.
  • Ensign Peak Advisors's portfolio value rose 6.7% quarter-over-quarter to $49.3B.

Based on Ensign Peak Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.